The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study
Publication
, Conference
Freedland, S; Boyer, MJ; Janes, J; Bennett, J; Thomas, VM; De Hoedt, AM; Abran, J; Aboushwareb, T; Salama, JK
Published in: EUROPEAN UROLOGY
February 2022
Duke Scholars
Published In
EUROPEAN UROLOGY
EISSN
1873-7560
ISSN
0302-2838
Publication Date
February 2022
Volume
81
Start / End Page
S1413 / S1414
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Freedland, S., Boyer, M. J., Janes, J., Bennett, J., Thomas, V. M., De Hoedt, A. M., … Salama, J. K. (2022). The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study. In EUROPEAN UROLOGY (Vol. 81, pp. S1413–S1414).
Freedland, S., M. J. Boyer, J. Janes, J. Bennett, V. M. Thomas, A. M. De Hoedt, J. Abran, T. Aboushwareb, and J. K. Salama. “The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study.” In EUROPEAN UROLOGY, 81:S1413–14, 2022.
Freedland S, Boyer MJ, Janes J, Bennett J, Thomas VM, De Hoedt AM, et al. The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study. In: EUROPEAN UROLOGY. 2022. p. S1413–4.
Freedland, S., et al. “The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study.” EUROPEAN UROLOGY, vol. 81, 2022, pp. S1413–14.
Freedland S, Boyer MJ, Janes J, Bennett J, Thomas VM, De Hoedt AM, Abran J, Aboushwareb T, Salama JK. The Oncotype DX Genomic Prostate Score® assay is associated with time to distant metastasis and prostate cancer death after external beam radiation therapy in localized prostate cancer: A retrospective study. EUROPEAN UROLOGY. 2022. p. S1413–S1414.
Published In
EUROPEAN UROLOGY
EISSN
1873-7560
ISSN
0302-2838
Publication Date
February 2022
Volume
81
Start / End Page
S1413 / S1414
Related Subject Headings
- Urology & Nephrology
- 3202 Clinical sciences